Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Garinot

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Toxicology and Applied Pharmacology|December 26, 2022
Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvantPatrick Syntin, Fabienne Piras-Douce, François Dalençon, et al.
Current Medicinal Chemistry|April 8, 2003
Cationic lipids for transfectionCéline Nicolazzi, Marie Garinot, Nathalie Mignet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2006
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approachAnne des Rieux, Virginie Fievez, Marie Garinot, et al.
Bioorganic & Medicinal Chemistry|March 14, 2007
Amphiphilic polyether branched molecules to increase the circulation time of cationic particlesMarie Garinot, Nathalie Mignet, Celine Largeau, et al.
Gene Therapy|November 1, 2022
Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccinesCamille Malburet, Laurent Leclercq, Jean-François Cotte, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 29, 2004
pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene deliveryChristophe Masson, Marie Garinot, Nathalie Mignet, et al.
Analytical Chemistry|March 7, 2022
Size and Charge Characterization of Lipid Nanoparticles for mRNA VaccinesCamille Malburet, Laurent Leclercq, Jean-François Cotte, et al.
Journal of Applied Toxicology : JAT|September 19, 2023
Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistributionKarine Broudic, Sébastien Laurent, Vladimir Perkov, et al.
International Journal of Pharmaceutics: X|August 11, 2020
A potent novel vaccine adjuvant based on straight polyacrylateMarie Garinot, Fabienne Piras-Douce, Patricia Probeck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 26, 2007
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccinationMarie Garinot, Virginie Fiévez, Vincent Pourcelle, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Toxicology and Applied Pharmacology|December 26, 2022
Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvantPatrick Syntin, Fabienne Piras-Douce, François Dalençon, et al.
Current Medicinal Chemistry|April 8, 2003
Cationic lipids for transfectionCéline Nicolazzi, Marie Garinot, Nathalie Mignet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2006
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approachAnne des Rieux, Virginie Fievez, Marie Garinot, et al.
Bioorganic & Medicinal Chemistry|March 14, 2007
Amphiphilic polyether branched molecules to increase the circulation time of cationic particlesMarie Garinot, Nathalie Mignet, Celine Largeau, et al.
Gene Therapy|November 1, 2022
Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccinesCamille Malburet, Laurent Leclercq, Jean-François Cotte, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 29, 2004
pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene deliveryChristophe Masson, Marie Garinot, Nathalie Mignet, et al.
Analytical Chemistry|March 7, 2022
Size and Charge Characterization of Lipid Nanoparticles for mRNA VaccinesCamille Malburet, Laurent Leclercq, Jean-François Cotte, et al.
Journal of Applied Toxicology : JAT|September 19, 2023
Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistributionKarine Broudic, Sébastien Laurent, Vladimir Perkov, et al.
International Journal of Pharmaceutics: X|August 11, 2020
A potent novel vaccine adjuvant based on straight polyacrylateMarie Garinot, Fabienne Piras-Douce, Patricia Probeck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 26, 2007
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccinationMarie Garinot, Virginie Fiévez, Vincent Pourcelle, et al.
Pageof 2